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Structured Abstract 
Aims: The diagnosis of gestational diabetes mellitus (GDM) during pregnancy can lead to anxiety.  
This study evaluated the impact of an innovative patient-centred educational DVD on anxiety and 
glycaemic control in women newly diagnosed with GDM.   
Methods: 150 multi-ethnic women, aged 19-44 years, from three UK hospitals were randomised to 
either usual care plus DVD (DVD group, n=77) or usual care alone (control group, n=73) at GDM 
diagnosis. Primary outcomes were anxiety (State-Trait Anxiety Inventory) and mean 1-hour 
postprandial capillary self-monitored blood glucose for all meals, on day prior to follow-up.  
Results: No significant difference between the DVD and control group were reported, for anxiety 
(37.7±11.7 vs 36.2±10.9; mean difference after adjustment for covariates (95%CI) 2.5 (-0.8, 5.9) or 
for mean 1-hour postprandial glucose for all meals (6.9±0.9 vs 7.0±1.2 mmol/L; -0.2 (-0.5, 0.2). 
However, the DVD group had significantly lower postprandial breakfast glucose compared to the 
control group (6.8±1.2 vs 7.4±1.9 mmol/L; -0.5 (-1.1, -<0.1; p=0.04).  
Conclusions: The results in this trial did not highlight any differences between those who received 
the intervention and those who received usual care. It is possible that women already felt supported 
by their frequent attendance at specialist clinics for monitoring and advice. Healthcare professional 
and family support are key elements to empowering women with GDM and require further 
consideration in future interventions. Nonetheless, educational resources such as this will be 
beneficial to help support women given the current resource and time implications of the year on year 
rises in the incidence of gestational diabetes. 
 
Keywords: gestational diabetes mellitus; patient education; randomised controlled trial; anxiety 
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1. Introduction 
Gestational Diabetes Mellitus (GDM) is currently defined as glucose intolerance first identified during 
pregnancy[1]. GDM is associated with increased perinatal morbidity[2,3],  and a 7-fold risk of 
developing type 2 diabetes in later life compared normoglycaemic pregnant women[4]. Research has 
focused on the effect of GDM treatment on pregnancy outcome[2,3] and on diagnostic criteria for 
GDM[5,6], leading to International Association of Diabetes and Pregnancy Study Group (IADPSG) 
recommendations on diagnosis criteria of GDM[6],  subsequently endorsed by the World Health 
Organisation[7].  Furthermore, the prevalence of GDM has been increasing, due in part to rising 
maternal obesity and diagnostic criteria changes, with 1 in 7 births globally now affected by diabetes 
in pregnancy, the majority of which, 80%, have GDM[8].  
Few resources have been directed at the educational and psychological needs of women with GDM. 
Studies to date have produced conflicting results, reporting a less positive experience of pregnancy[9]; 
increased reactive anxiety which then dissipated[10]  and no differences in bipolar affective 
states[11,12]. Qualitative studies link GDM diagnosis with shock, fear and anxiety[13-14], with one 
study describing the experience as ‘from stun to gradual balance’[15]. Increasing knowledge and skills 
of women with GDM results in a sense of empowerment and regaining control of their lives, reducing 
vulnerability and uncertainty[13] with peer support networks suggested as potential educational 
techniques[14]. Recent qualitative research by our group in a multicentre, multi-ethnic study reported 
a need for advice from diabetes care team to be more individualised, and culturally appropriate, and 
highlighted a lack of availability of reliable high quality information, in a user-friendly format[16]. 
Diabetes educational interventions should be multicomponent, aiming to empower patients, target 
lifestyle changes and encourage self-efficacy and self-management[17], with CD-ROM/DVD media 
reported as feasible and effective educational interventions in people with diabetes[18].  
Women diagnosed with GDM are referred to antenatal-metabolic clinics for specialist medical and 
obstetric care from multi-disciplinary teams. Patient education is crucial and a woman’s understanding 
of her condition will influence treatment compliance[19].  Women diagnosed with GDM face a steep 
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learning curve; they are advised of associated risks of GDM, to adapt their diet and lifestyle, to self-
monitor blood glucose and meet individualized targets and may have to inject insulin. Thus, there is 
an urgent need for novel approaches to support healthcare professionals (HCP’s) in the delivery of 
education to women diagnosed with GDM [16]. Apart from some locally produced leaflets there is 
currently a dearth of user-friendly material available to women newly diagnosed with GDM. Hence we 
developed a novel evidence based educational DVD for women newly diagnosed with GDM.  
The aim of this study was to determine the impact of the DVD on maternal anxiety and blood glucose 
control in pregnant women diagnosed with GDM for the first time. 
 
2. Methods 
2.1. Study design  
A multicentre randomised controlled trial was conducted in joint antenatal-metabolic clinics of three 
UK NHS hospitals in Northern Ireland and Manchester. Pregnant women newly diagnosed with GDM 
were randomised to one of two parallel arms in a 1:1 ratio between January 2013 and January 2014. 
The experimental arm received the DVD in addition to usual care. The control arm received usual 
care alone. Ethical approval was granted by the Office for Research Ethics Committees Northern 
Ireland and at each of the participating sites. The trial was registered with ISRCTN (International 
Standard Registered Clinical/soCial sTudy Number), number 6268558. 
2.2.  Subjects 
Women were assessed for eligibility if over 16 years old, with a recent new diagnosis of GDM as per 
IADPSG criteria [fasting plasma glucose ≥ 5.1 mmol/l (92 mg/dl) or a random plasma glucose ≥ 11.1 
mmol/l  or a OGTT (Oral Glucose Tolerance Test)  result FPG ≥ 5.1 mmol/l  (92 mg/dl) or a 1-h plasma 
glucose ≥ 10.0 mmol/l  (180 mg/dl) or a 2-h plasma glucose ≥ 8.5 mmol/l  (153 mg/dl)]. Women were 
excluded if: diagnosed with GDM in a previous pregnancy or type 1 or type 2 diabetes during the 
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current pregnancy; participating in another research study or deemed inappropriate to take part by 
their Consultant. 
Women who met the inclusion criteria were approached by a diabetes care team member, given a 
study information sheet and permission sought for the researcher to speak to them (HCP completed 
a notification of interest slip). The researcher explained the study to each woman, and if willing to take 
part full written informed consent was obtained. Interpreters were used when required. 
2.3. Intervention 
The intervention was a 46-minute educational DVD designed to complement advice provided by the 
multidisciplinary diabetes care team. The DVD was developed and evaluated using focus group 
methodology across 2 distinctly different populations with regard to ethnic mix and culture (Northern 
Ireland and Manchester) with the aim of designing a DVD with wide appeal. The tone and content 
were directed by focus groups with women with GDM[16]. A multidisciplinary HCP project steering 
committee ensured content validity. The DVD comprises three distinct sections: What is Gestational 
Diabetes; Living with Gestational Diabetes and Life after Gestational Diabetes, with practical guides 
on blood glucose self-monitoring, administering insulin, calculating BMI post-pregnancy and healthy 
eating. It features women with GDM from different ethnic backgrounds, sharing their views and 
experiences, alongside an evidence-based commentary adhering to NICE guidelines[19]. 
Recommended psychological targets[20] are interwoven into the DVD content, for example, helping 
women to develop accurate knowledge about health consequences of their lifestyle in relation to 
GDM, helping women identify the potential consequences of their behaviour, enhancing social 
approval for positive health behaviours and promoting positive feelings towards outcomes for both 
the woman and her baby. The DVD was available in English, Urdu, Somali and Arabic. 
2.4. Randomisation (sequence generation) 
Eligibility was checked by the researcher. The Northern Ireland Clinical Research Support Centre 
confirmed eligibility and assigned the next available unique patient number and treatment allocation 
(control or experimental group). The randomisation list was computer-generated with random variable 
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block lengths. Stratification was used to randomize participants to treatment group, balancing 
simultaneously on several relevant factors (ethnicity, centre and parity).  The study was not blinded 
as the researcher issued the DVD and contacted women to remind them to view the DVD twenty-four 
hours post-randomization. 
2.5. Procedures 
The control arm received usual care. The experimental arm received the DVD in addition to usual 
care.  Patients were managed according to NICE guidelines[19], with Clinicians committed to 
harmonising care across study sites. Ideally, women were recruited at their first antenatal-metabolic 
clinic visit post-GDM diagnosis, or the next scheduled clinic visit if this was not possible. Study visits 
took place at randomization (baseline/visit 1), 2 weeks after randomization (visit 2) and 6-8 weeks 
post-delivery (visit 3/end of trial) to coincide with scheduled appointments (Figure 1). Clinical and 
demographic data was collected on all women. At baseline, visit 2 and 3, data was collected using 
standardised instruments with demonstrated validity, reliability and sensitivity to change. These were 
the State form of the State-Trait Anxiety Inventory (STAI)[21], Prenatal Distress 
questionnaire (PDQ)[22,23], Appraisal of diabetes scale (ADS)[24], Diabetes Empowerment Scale 
(DES)[25,26] and Risk Perception Survey for Developing Diabetes (RPS-DD)[27] (visit 3 only); (See 
supplementary data for further detail on standardised instruments). Knowledge of GDM was assessed 
using a short study specific questionnaire designed and tested during the development process (visit 
2 & 3 only). Women in the treatment arm were asked to verifying engagement with the DVD and give 
feedback regarding the resource.  
Other data relating to usual care and treatment regimens were obtained from patient notes. Women 
were offered a standardised capillary blood glucose meter and asked to record an 8-point glucose 
profile for 24 hours prior to visit 2 (Fasting glucose; 1-hour post-breakfast; Pre-lunch; 1-hour post-
lunch; Pre-dinner; 1-hour post-dinner; Pre-supper; 1-hour post-supper). As it was anticipated that 
there would be loss to follow-up at the postnatal visit (visit 3), women were contacted and 
questionnaires completed by telephone if they did not attend visit 3 to maximise data collection.   
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2.6. Outcomes 
The primary outcomes were maternal anxiety at visit 2 (2 weeks post-randomization) as measured by 
the STAI[21] and mean 1-hour post-prandial glucose calculated from an 8 point glucose profile in the 
24-hour period prior to visit 2 (self-blood glucose monitoring).  
Secondary outcomes were pregnancy specific stress (PDQ)[22,23], emotional adjustment to diabetes 
(ADS)[23], self-efficacy (DES)[25,26] and knowledge of GDM at visit 2, and risk perception for 
developing diabetes (RPS-DD)[27] at visit 3.   
2.7. Sample size 
It was estimated that 140 patients would give 80% power to detect (p<0.05; two-tailed) a difference 
in means between groups, of a five point change on the STAI score, (assuming an interpatient 
standard deviation of 10.5 for STAI state anxiety score[28]). To allow for practice and patient attrition, 
a total sample size of 150 (75 per group) needed to be recruited. Baseline STAI scores were included 
as a covariate in an analysis of covariance to improve study power. Assuming an inter-patent standard 
deviation of 1.05 for post-prandial glucose as measured by self-monitoring of blood glucose a total 
sample of 140 patients recruited was estimated to give 80% power to detect (p<0.05; two-tailed) a 
0.5 mmol/l reduction in mean 1-hour post-prandial blood glucose. 
2.8. Analysis 
Analysis was by intention to treat. Pre-specified subgroup analysis for the primary endpoints was 
carried out according to treatment at visit 2 (diet only, tablet or insulin). Data were entered into the 
Statistical Product and Service Solutions (SPSSv21). Descriptive statistics were used to analyse 
participant baseline characteristics; independent t-tests and chi-square were performed to determine 
if there was any significant relationships between the variables measured. 
3. Results 
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A total of 307 women were screened for eligibility, 157 were excluded from the study and 150 were 
randomized (DVD plus usual care n=77, usual care alone n=73). Eight women were lost in follow–up 
at visit 2; analyses was completed on the data from 142 women (Figure 1). Baseline characteristics 
are reported in Table 1. Women were aged between 19-44 years. The majority in both groups were 
white, employed and had a partner. More women in the DVD group were in the highest social 
deprivation fifth, indicating more social deprivation when compared to those in the control group.  
Women were recruited on average 5.7±5.0 days after diagnostic blood tests were performed (visit 1). 
Participants returned for visit 2 at a mean±SD of 2.5±1.6 weeks after randomisation. In total, 75.3% 
(n=58) reported viewing the DVD. 
Mean scores for the STAI questionnaire (visit 2) was the primary outcome measure of anxiety. No 
significance difference was found between the DVD group and control group for anxiety (37.7±11.7 
vs 36.2±10.9; mean difference after adjustment for covariates (95%CI) 2.5 (-0.8, 5.9) (Table 2, 
covariates: centre, parity and ethnicity and visit 1 questionnaire. A planned sub-analysis by the three 
treatment regime groups was also conducted (1) diet only; 2) oral glycaemic lowering medication only; 
3) insulin only and insulin in combination with an oral glycaemic lowering medication), and again no 
significant differences were observed (See Supplementary Data).  
No significant difference was observed between the DVD and control groups for the primary outcome 
of mean 1-hour postprandial self-reported capillary blood glucose for all meals on the day prior to visit 
2, adjusted for covariates ((6.9±0.9 vs 7.0±1.2 mmol/L; -0.2 (-0.5, 0.2)) (Table 3; covariates: centre, 
parity, ethnicity and social deprivation score). In a planned sub-analysis, differences between the DVD 
and control group were examined for blood glucose pre and post mealtimes. One-hour post-breakfast 
blood glucose was significantly lower in the DVD group when compared to the control group (6.8±1.2 
vs 7.4±1.9 mmol/L; -0.5 (-1.1, -<0.1; p=0.04) (Table 3). No significant differences were noted for other 
mealtimes. When examined by treatment regime women on oral medication and/or insulin had 
significantly lower blood glucose 1-hour post-breakfast and 1-hour post-lunch compared to diet or oral 
medication only (See Supplementary Data). 
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Secondary outcomes: A mean score was calculated for the PDQ [22,23], ADS [24], DES [25,26] and 
knowledge of GDM questionnaires at visit 2. No significant differences were noted between the DVD 
and control group, when unadjusted or adjusted for covariates (centre, parity and ethnicity and visit 1 
questionnaire), in pregnancy specific stress, emotional adjustment to diabetes, self-efficacy and 
knowledge (table 2).  
In relation to modifiers of risk perception (RPS-DD)[27] measured post-partum (visit 3), no significant 
differences were observed between the DVD and control group for personal control, optimistic bias 
or knowledge of diabetes risk factors. While the score for ‘benefits and barriers’ was lower in the DVD 
group when compared to the control group, this did not reach statistical significance (Table 4). When 
women were asked about their risk perception of developing diabetes over the next 10 years, fewer 
women in the DVD group felt they had ‘moderate chance & high chance’ when compared to the control 
group. No difference was observed between the groups when asked how they felt their risk perception 
for developing diabetes in the next 10 years if they did not change their lifestyle (Table 4). 
Within the intervention group feedback in relation to the DVD was positive. Using a scale of 0-10, 84% 
rated the DVD 7 or above for usefulness (10, very useful), and 88% rated it 7 or above when asked if 
they would recommend it to a friend (10, very strongly recommend). Women described the DVD as 
‘reassuring’, ‘a fantastic tool’, that ‘provided a lot of information in a quick and easy way’ and ‘helped 
reinforce all the information from clinic’. 
 
4. Discussion 
This multi-centre trial of a novel patient-centred educational DVD, designed for women diagnosed 
with GDM, revealed no significant differences in maternal anxiety or in mean 1-hour post-prandial 
glucose in the 24 hour period prior to visit 2, between those who received the DVD in addition to usual 
care and those who received usual care alone. Nonetheless, women were extremely positive about 
the DVD in terms of usefulness. 
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The mean baseline and post-intervention STAI-S scores (anxiety) reported here were relatively high 
but similar to other studies of pregnant women[28]. While it was anticipated that increasing women’s 
knowledge on GDM would decrease anxiety[15], it is possible that women diagnosed with GDM in 
our study did not have increased levels of anxiety as previously reported[10, 12]. Study setting may 
have influenced levels of anxiety in this and other studies. Women were recruited from research active 
specialist antenatal-metabolic clinics where repeated contact with diabetes care team HCP‘s and 
opportunities for support and education are likely to have been available[17]. Thus, while qualitative 
work carried out in these centres highlighted a lack of availability of reliable high quality information, 
in a user-friendly format[16], it is possible that women felt adequately supported and informed. In 
addition, how a woman copes with GDM diagnosis depends on her identity, attitude, and resources, 
including HCP and ‘family and friends’ networks[29]. This patient group appear well supported as the 
majority have a partner, and given the high education attainment and low percentage living in areas 
of social deprivation, they may be well educated and motivated to control their condition 
independently. Other validated psychological measures for pregnancy specific distress, emotional 
adjustment and self-efficacy were also assessed but no differences were apparent between the two 
groups for these secondary outcomes, which again may suggest adequate support for these women 
within specialist clinics adhering to NICE guidelines[19]. 
There was no impact of the DVD on mean 1-hour post-prandial glucose. Similarly, O’Dea and 
Colleagues did not find any significant impact of a group-based lifestyle intervention on blood glucose 
parameters in women with prediabetes following GDM[30]. However, the current study found that 
one-hour post-breakfast blood glucose was lower in the DVD group when compared to the control 
group. Analysis according to treatment regime suggests that the benefits seen in relation to post-
prandial blood glucose are in those women on medication and/or insulin. While specific guides within 
the DVD regarding blood glucose monitoring, insulin administration and healthy eating may have 
helped women within the DVD group on medication and or insulin to achieve better blood glucose 
control, the association was weak, and may be a chance finding.   
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When examining modifiers of risk perception for developing diabetes in the future, women randomised 
to the DVD group were similar to those in the control group. However, when asked about risk 
perception of developing diabetes over the next 10 years significantly fewer women believed they had 
moderate/high chance compared to the control group. One explanation may be that those women 
who engaged with the DVD are more highly motivated to make the changes necessary to their diet 
and lifestyle to prevent the development of type 2 diabetes, thus believe that they are at less risk.  
A major strength of this randomised controlled trial was its multi-centre design allowing recruitment of 
a multi-ethnic population. Interpreters were used where necessary, with questionnaires and DVDs 
available in four languages. Randomisation was stratified by race and centre to ensure equitable 
distribution of the intervention across centres and ethnicity. This increases the generalisability of 
results. Nonetheless, when interpreting results consideration must be given to the finding that the 
population appeared to be relatively highly educated. Given the nature of the intervention it was not 
possible to blind the researcher, although all questionnaires were self-completed by women, and 
anonymised prior to analysis to reduce risk of bias. Glycaemic control was self-reported, and there is 
the possibility that patients may not have been monitoring as frequently as required, or that they may 
have recorded an incorrect reading if outside their recommended limits.  
5. Conclusion 
In summary, the incidence of GDM is increasing. Women newly diagnosed with GDM need support 
and education at time of diagnosis. Patient education is an important aspect of care, yet HCP’s are 
under pressure due to increasing numbers. Hence, novel ways of educating the patient must be 
developed, evaluated and made available for women and HCPs. Although the results in this research 
did not highlight any differences between those who received the DVD and those who received usual 
care, other factors, such as existing support networks need to be considered. Women who received 
the DVD were positive about the resource in terms of usefulness to reinforce all the information from 
clinic. As a result of positive feedback from women and HCPs involved in this trial the resource has 
been made available for wider use in an online format: www.womenwithgestationaldiabetes.com  The 
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findings reported here support increasing evidence that lifestyle interventions work for some and not 
for others, and that support from HCP’s and family may have an impact on intervention effectiveness. 
Hence these factors need to be considered when further developments of current or new interventions 
are considered. 
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Table 1. Baseline general characteristics by treatment group 
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Values are mean (SD) for continuous variables and n (%) for categorical variables. Differences 
between the groups were assessed using independent samples t-tests and chi-squared test. 
 
 
 
 
 
  
 DVD +   
usual care 
n= 77 
Usual care 
n=73 
Age at V1 (yr)  32.3 (6.2) 31.7 (5.9) 
Height (cm)  163.0  (7.0) 160.3  (7.5) 
Weight  at booking (kg)  78.5  (21.3) 80.4 (17.2) 
BMI at booking (kg/m2)  29.5 (7.1) 31.1 (6.5) 
Nulliparous  35 (45.5) 33 (45.2) 
Ethnicity White 50 (64.9) 47 (64.4)                   
 
Black African/ 
Caribbean/other 8 (10.4) 3 (4.1) 
 
Indian or  
Bangladeshi 3 (3.9) 8 (11.0) 
 Pakistani 11 (14.3) 11 (15.1) 
 Other 5 (6.5) 4 (5.5) 
Current smoker   3 (3.9) 2 (2.9) 
Years education (yr)  15.2 (2.9) 15.1 (2.6) 
Social deprivation score fifths  1 (least deprived) 32 (41.6) 33 (45.2) 
 2 13 (16.9) 13 (17.8) 
 3 9 (11.7) 15 (20.5) 
 4 7 (9.1) 5 (6.8) 
 5 (most deprived) 16 (20.8) 7 (9.6) 
Employment status employed 50 (65.8) 44 (60.3) 
 unemployed 23 (30.3) 25 (34.2) 
 not known 3 (3.9) 4 (5.5) 
Partner yes 64 (83.1) 65 (89.0) 
 no 10 (13.0) 7 (9.6) 
 not known 3 (3.9) 1 (1.4) 
Gestational age at diagnosis 
(wk)  27.5 (4.6) 26.8 (4.5) 
Gestational age at delivery (wk)  38.3 (1.3) 37.8 (2.0) 
Treatment at delivery diet only 29 (38.2) 23 (32.4) 
 metformin 21 (27.6) 17 (23.9) 
 insulin 16 (21.1) 16 (22.5) 
 metformin & insulin 10 (13.2) 15 (21.1) 
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Table 2. Differences in anxiety, stress, self-efficacy, emotional adjustment and knowledge at 
visit 2 between patients randomised to educational DVD + usual care or usual care alone 
Questionnaire DVD +        
Usual care 
(n= 75) 
Usual care 
(n=67) 
Mean Difference 
(95% CI) 
p 
Anxiety  (State-Anxiety) 37.7 (11.7) 36.2 (10.9) 1.6 (-2.2, 5.4) 0.413 
2.3 (-1.0, 5.7) 0.175* 
Pregnancy Specific Stress 
(PDQ) 
13.8 (6.9) 12.7 (7.3) 1.2 (-1.4, 3.7) 0.362 
1.4 (-0.2, 3.0) 0.085* 
Emotional Adjustment to 
Diabetes (ADS) 
17.1 (4.0) 16.9 (3.8) 0.2 (-1.1, 1.5) 0.762 
0.3 (-0.9, 1.4) 0.659* 
Self-Efficacy (DES) 4.0 (0.7) 3.9 (0.8) 0.1 (-1.2, 0.3) 0.650 
0.1 (-0.1, 0.3) 0.301* 
Knowledge of GDM 14.7 (2.2) 14.8 (2.1) -0.1 (-0.8, 0.6) 0.833 
-0.5 (-1.1, 1.6) 0.144* 
Values are mean (SD). Differences between the groups were assessed using independent samples t-tests 
and *adjusted for centre, parity and ethnicity and visit 1 questionnaire.  
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Table 3. Differences in self-reported blood glucose readings 24-hours prior to visit 2 between patients randomised to educational 
DVD + usual care or usual care alone 
 DVD + Usual care 
n= 75 
Usual care 
n=67 
Mean difference  
(95% CI) 
P-value 
1 hour post-prandial blood glucose for 
all meals (mmol/l) 
6.9 (0.9) 
 
7.0 (1.2) 
 
-1.2 (-0.5, 0.2) 0.33 
-0.2 (-0.5, 0.2) 0.45* 
Fasting blood glucose for all meals 
(mmol/l) 
5.1 (0.6) 
 
5.2 (0.7) 
 
-0.1 (-0.3, 0.2); 0.61 
-0.1 (-0.2, 0.3) 0.58* 
Pre-breakfast blood glucose (mmol/l) 5.3 (0.7) 
 
5.2 (0.7) 
 
<0.1 (-0.2, 0.3); 0.70 
<0.1 (-0.2, 0.3); 0.80* 
1-hour post-breakfast blood glucose 
(mmol/l) 
6.8 (1.2) 
 
7.4 (1.9) 
 
-0.6 (-1.1, -<0.1); 0.04 
-0.5 (-1.2, -<0.1); 0.05* 
Pre-lunch blood glucose (mmol/l) 5.0 (0.8) 
 
4.9 (0.8) 
 
<0.1 (-0.3, 0.3) 0.79 
<0.1 (-0.2, 0.4) 0.69* 
1-hour post-lunch blood glucose for 
(mmol/l) 
6.7 (1.0) 
 
6.7 (1.5) 
 
<0.1 (-0.4, 0.5); 0.99 
<-0.1 (-0.5, 0.5); 0.99* 
Pre-dinner blood glucose (mmol/l) 5.1 (1.0) 
 
5.3 (1.1) 
 
-0.2 (-0.6, 0.2); 0.25 
-0.2 (-0.6, 0.2); 0.30* 
1-hour post-dinner blood glucose for 
(mmol/l) 
6.9 (1.2) 
 
7.1 (1.3) 
 
-0.2 (-0.7, 0.3); 0.37 
-0.2 (-0.7, 0.3); 0.42* 
Values are mean (SD). Differences between the groups were assessed using independent samples t-tests and *adjusted for centre, parity , 
ethnicity and social deprivation score. 
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Table 4.  Modifiers of risk perception and risk perception and lifestyle modification over the next 10 years from the Risk Perception 
Survey for Developing Diabetes (RPS-DD) administered at visit 3 by treatment group  
 
Values are mean (SD) and n (%).  Differences between the groups were assessed using independent samples t-tests and chi-squared test and adjusted for 
centre, parity, ethnicity and social deprivation score in fifths.  
Personal control and optimistic bias: higher scores reflected greater personal control and greater optimistic bias for not developing diabetes.  
Knowledge of diabetes: higher scores reflect a greater knowledge of the risk factors 
Benefits and barriers: higher scores indicate greater belief in the benefits of preventative activity and lower scores indicate greater barriers. 
  DVD + Usual care 
(n=49) 
Usual care 
(n=55) 
Mean difference    
(95% CI) 
p-value Adjusted 
p-value 
Personal Control(range 1-4)  3.20 (0.44) 3.21 (0.50) 0.01 (-0.19, 0.21) 0.91 0.84 
Optimistic bias (range 1-4)  2.08 (0.81) 2.01 (0.63) -0.06 (-0.36, 0.23) 0.66 0.86 
Knowledge of diabetes (range 1-11)  6.29 (1.89) 6.31 (2.00) 0.42 (-0.82, 0.86) 0.96 0.70 
Benefits and barriers (range 1-6)  3.74 (0.76) 4.02 (0.75) 0.28 (-0.04, 0.06) 0.08 0.08 
Risk perception of developing 
diabetes over the next 10 years 
No chance &   
slight chance 
29 (58.0) 14 (32.6)  
0.02 0.02 Moderate & 
high chance 
 
21 (42.0) 28 (66.7)  
Risk perception of diabetes in next 
10 years if lifestyle does not change 
No chance & 
slight chance 
16 (31.4) 11 (26.2)   
0.58 
 
0.55 Moderate & 
high chance 35 (68.6) 31 (73.8) 
 
  Assessed for eligibility 
n=307 
Excluded n=157 
• Not meeting inclusion criteria n =19 
• Declined n=101 
• Other reasons n=37 
 
Randomised 
n=150 
DVD + standard care 
n=77 
Standard care alone 
n=73 
Lost to follow-up at V2  
 n= 2 
• Withdrew consent n=1 
• Moved n=1 
 
Lost to follow-up at V2  
n=6 
• Withdrew consent n=1 
• Moved n =1 
• Premature delivery n=3 
• Questionnaires too 
   
Completed Visit 2 (primary outcome) 
n= 142 
Completed visit 3 (postnatal) 
n= 118 
 
Instruments used 
Maternal anxiety was assessed using the Spielberger State-Trait Anxiety Inventory (STAI). 
Using a 4-point scale ranging from 1 (not at all) to 4 (very much), participants rate 20 items 
(e.g. “I am worried” and “I feel calm” “right now…at this moment”) on the state form of the 
STAI. [1] A 5 point change on the STAI scale is deemed to be a clinically worthwhile change. 
A reduction of 5 scale points in the STAI-S would indicate a change in state anxiety 
equivalent to one-half of the baseline standard deviation in a similar population  
Pregnancy specific stress was assessed using the Prenatal Distress Questionnaire (PDQ) 
which assesses specific worries and concerns pertaining to pregnancy, including concerns 
about medical problems and the health of the baby. This instrument was designed to be 
administered prospectively during mid-pregnancy and contains 12 concise items, which 
require less than 5 min to complete. The PDQ is a standardized measurement tool with good 
reliability and good structural validity [2,3]. 
Emotional adjustment to diabetes was assessed using the appraisal of diabetes scale (ADS), a 
brief screening tool of 7 questions, rated on a five-point Likert scale, to measure control, 
uncertainty, coping, effects of life goals, predictive view of and degree of distress caused by 
diabetes [4].  
Self-efficacy was assessed using the Diabetes Empowerment Scale (DES) – short form, which 
assesses diabetes related psychosocial self-efficacy such as obtaining social support, 
managing stress, in an 8 item short form of the DES, rated on a five-point Likert scale: 
1=Strongly disagree, 5=Strongly agree [5,6].  
Risk Perception for Developing Diabetes was assessed using the Risk Perception Survey for 
Developing Diabetes (RPS-DD), adapted for women with histories of gestational diabetes. A 
self-administered or telephone interview questionnaire that assesses risk perception and 
modifiers of risk perception among women with histories of GDM who have not developed 
postpartum diabetes. The instrument contains 4 scales assessing modifiers of risk perception. 
These scales assess the patients' knowledge of diabetes risk factors, perceptions of personal 
control, optimism about developing diabetes and other diseases, and perceptions of the 
benefits and barriers of preventive behaviours [7].  
Finally, knowledge of gestational diabetes was assessed using a short questionnaire designed 
and tested during the development process with questions aligned to NICE guidance for 
management of GDM. As well as assessing knowledge of the GDM in all participants, this 
questionnaire had an additional component for those in the treatment arm to verify 
engagement with / viewing of the DVD, and give feedback regarding the resource.  
 
1) Spielberger, C.D. (1983) Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: 
Consulting Psychologist Press. 
2) Lobel, M., DeVincent, C.J., Kaminer, A., Meyer, B.A. The impact of prenatal maternal 
stress and optimistic disposition on birth outcomes in medically high-risk women. Health 
Psychology 2000; 19, 544–553. 
3) Yali, A.M., Lobel, M., 1999. Coping and distress in pregnancy: an investigation of medically 
high risk women. Journal of Psychosomatic Obstetrics and Gynecology 20, 39–52. 
4) Carey MP, Jorgensen RS, Weinstock RS, Sprafkin RP, Lantinga LJ, Carnrike CL Jr et al. 
Reliability and validity of the appraisal of diabetes scale. Journal of Behavioural Medicine 
1991; 14: 43–51. 
5) Anderson RM, Fitzgerald JT, Gruppen LD, Funnell MM, Oh MS: The diabetes 
empowerment scale-short form (DES-SF). Diabetes Care 2003; 26:1641-1643  
6)  University of Michigan Diabetes Research and Training Center, Diabetes 
EmpowermentScale-ShortForm(DES-SF) 
http://www.med.umich.edu/mdrtc/profs/documents/svi/DES-SF_english.pdf. Accessed 09 
Dec 2010 
7)  Kim C, McEwen LN, Piette JD, Goewey J, Ferrara A, Walker EA. Risk Perception for 
Diabetes among Women with Histories of Gestational Diabetes Mellitus. Diabetes Care 
2007; 30: 2281-2286. 
 
 
 
Differences in anxiety, stress, self-efficacy, emotional adjustment and knowledge by treatment regime at visit 2 between patients randomised to standard care 
or standard care + educational DVD.  
 
 Dietary Treatment Only Oral Medication Oral Medication +Insulin or Insulin Only 
 Standard 
Care + DVD 
Standard 
Care 
Mean difference 
(CI) 
P-value Standard 
Care + DVD 
Standard 
Care 
Mean  
difference (CI) 
P-value Standard 
Care + DVD 
Standard 
Care 
Mean 
difference (CI) 
P-value 
Anxiety  (State-Anxiety) 37.3 ( 12.2) 
 
35.0 (10.4) 
 
2.3 (-2.5, 7.1) 0.341 38.3 (11.8) 
 
33.7 (8.3) 
 
4.6 (-3.9, 13.1) 0.278 39.2 (9.6) 
 
42.8 (1.0) 
 
-3.6 (-13.9, 6.8) 0.483 
2.5 (-1.6, 6.6) 0.223* 5.8 (-3.2, 14.8) 0.196* -0.8 (-11.5, 1.0) 0.880* 
Pregnancy Specific Stress 
(PDQ) 
13.6 (5.5) 
 
12.7 (7.1) 
 
0.9 (-1.9, 3.6) 0.533 14.1 (8.3) 
 
11.4 (6.7) 
 
2.7 (-4.3, 9.3) 0.415 14.4 (10.6) 
 
13.6 (8.8) 
 
0.9 (-8.3, 10.1) 0.839 
1.6 (-0.5, 3.7) 0.130* 1.7 (-2.5, 5.8) 0.404* -0.5 (-3.5, 2.6) 0.749* 
Emotional Adjustment to 
Diabetes (ADS) 
16.8 (4.1) 
 
16.4 (3.6) 
 
0.5 (-1.2, 2.1) 0.578 17.3 (4.3) 
 
16.8 (4.9) 
 
0.4 (-3.2, 4.1) 0.811 18.2 (3.3) 
 
18.2 (3.3) 
 
-0.6 (-3.5, 2.2) 0.644 
0.3 (-1.1, 1.6) 0.697* 0.1 (-3.4, 3.5) 0.969* -0.6 (-3.1, 2.0) 0.632* 
Self-Efficacy (DES) 4.0 (0.7) 
 
3.9 (0.8) 
 
0.1 (-0.2, 0.4) 0.572 4.1 (0.4) 
 
4.2 (0.6) 
 
<-0.1 (-0.4, 0.4) 0.970 3.7 (1.0) 
 
3.8 (0.6) 
 
-0.1 (-0.8, 0.6) 0.692 
0.2 (-0.1, 0.4) 0.290* 0.2 (-0.3, 0.7) 0.384* <-0.1 (-0.7, 0.6) 0.885* 
Knowledge of GDM 14.4 (1.9) 
 
14.7 (2.1) 
 
-0.3 (1.2, 0.5) 0.422 15.3 (2.5) 
 
15.1 (2.3) 
 
0.2 (-1.8, 2.1) 0.857 15.4 (2.5) 
 
14.7 (2.1) 
 
0.7 (-1.4, 2.7) 0.507 
-0.5 (-1.2, 0.2) 0.159* -0.2 (-2.5, 2.2) 0.874* 0.4 (-1.9, 2.7) 0.733* 
Values are mean (SD). Differences between the groups were assessed using independent samples t-tests and *adjusted for centre, parity and ethnicity and visit 1 questionnaire 
 
 
 
 
 
Differences in self-reported blood glucose readings 24-hour prior to visit 2 between patients randomised to standard care or standard care + educational DVD.  
 Dietary Treatment Only Oral Medication Oral Medication +Insulin or Insulin Only 
 Standard 
Care + DVD 
Standard 
Care 
Mean difference 
(CI) 
P Standard 
Care + DVD 
Standard 
Care 
Mean 
difference (CI) 
P Standard 
Care + DVD 
Standard 
Care 
Mean 
difference (CI) 
P 
1 hour post-prandial blood 
glucose for all meals (mmol/l) 
6.7 (0.7) 6.8 (1.1) -0.1 (-0.5, 0.3) 0.645 7.1 (1.2) 5.1 (0.7) 0.3 (-0.5, 1.1) 0.482 7.2 (1.0) 
 
8.1 (1.4) 
 
-0.8 (-1.9, 0.2) 0.121 
0.1 (-0.5, 0.3) 0.610* 0.4 (-0.4, 1.1) 0.321* -0.9 (-2.1, 0.3) 0.137* 
Fasting blood glucose for all meals 
(mmol/l) 
5.0 (0.5) 
 
5.1 (0.7) 
 
-0.1 (-0.4, 0.2) 0.420 5.1 (0.8) 
 
5.1 (0.8) 0.1 (-0.5, 0.6) 0.811 5.5 (0.7) 5.4 (0.7) 0.1 (-0.5, 0.7) 0.735 
-0.1 (-0.4, 0.2) 0.509* <0.1 (-0.6, 0.6) 0.989* -0.1 (-0.7, 0.6) 0.906* 
Pre-breakfast blood glucose 
(mmol/l) 
5.2 (0.6) 
 
5.2 (0.6) <0.1 (-0.3, 0.3) 0.914 5.5 (0.7) 
 
5.0 (0.7) 
 
0.4 (-0.2, 1.0) 0.142 5.6 (1.2) 
 
5.7 (0.6) 
 
-0.1 (-1.0, 0.7) 0.756 
<0.1 (-0.3, 0.3) 0.901* 0.3 (-0.4, 0.9) 0.388* -0.3 (-1.2, 0.5) 0.422* 
1-hour post-breakfast blood 
glucose (mmol/l) 
6.6 (0.9) 
 
7.0 (1.6) 
 
-0.4 (-0.9, 0.2) 0.186 7.5 (1.7) 
 
7.6 (2.4) 
 
-0.1 (-1.8, 1.6) 0.875 6.9 (1.6) 
 
8.5 (1.8) 
 
-1.6 (-3.2, -0.1) 0.038 
-0.4 (-1.0, 0.1) 0.124* 0.1 (-1.1, 1.4) 0.845* -1.3 (-3.0, 0.3) 0.109* 
Pre-lunch blood glucose (mmol/l) 
 
5.0 (0.7) 
 
5.0 (0.8) 
 
<-0.1 (-0.3, 0.3) 0.975 5.0 (1.1) 
 
4.8 (1.2) 
 
0.1 (-0.8, 1.1) 0.781 5.1 (0.6) 
 
5.0 (0.5) 
 
0.2 (-0.4, 0.7) 0.501 
<0.1 (-0.3, 0.4) 0.854* 0.2 (-0.9, 1.2) 0.770* 0.2 (-0.4, 0.9) 0.477* 
1-hour post-lunch blood glucose 
for (mmol/l) 
6.8 (1.1) 
 
6.6 (1.4) 
 
0.2 (-0.4, 0.7) 0.552 6.7 (0.9) 
 
5.9 (0.6) 0.8 (0.2, 1.4) 0.014 6.8 (1.0) 
 
8.0 (1.8) 
 
-1.2 (-2.6, 0.2) 0.97 
0.2 (-0.3, 0.8) 0.416* 0.7 (<-0.1, 1.4) 0.055* -1.6 (-3.1, -0.2) 0.030* 
Pre-dinner blood glucose (mmol/l) 4.9 (0.8) 5.1 (0.9) -0.2 (-0.6, 0.2) 0.317 5.0 (0.8) 5.4 (0.9) -0.4 (-1.1, 0.3) 0.227 6.1 (1.5) 
 
6.1 (1.5) 
 
0.3 (-1.4, 2.0) 0.692 
-0.2 (-0.6, 0.2) 0.399* -0.5 (-1.3, 0.3) 0.204* -<0.1 (-2.0, 1.9) 0.958 
*1-hour post-dinner blood glucose 
for (mmol/l) 
6.7 (1.1) 
 
6.9 (1.1) 
 
-0.1 (-0.7, 0.4) 0.593 6.8 (1.4) 
 
7.1 (1.0) 
 
-0.3 (-1.4. 0.7) 0.502 8.0 (1.1) 
 
7.7 (1.8) 
 
0.3 (-1.2, 1.8); 0.699 
-0.1 (-0.7, 0.4) 0.644* -0.2 (-1.3, 0.9) 0.700* <0.1 (-1.8, 1.9) 0.944* 
Values are mean (SD). Differences between the groups were assessed using independent samples t-tests and *adjusted for centre, parity and ethnicity  
